EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 180 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,733 | -14.4% | 236,902 | +5.5% | 0.02% | -11.1% |
| Q2 2023 | $4,361 | -28.6% | 224,576 | +4.2% | 0.02% | -33.3% |
| Q1 2023 | $6,108 | -9.7% | 215,431 | -7.0% | 0.03% | -18.2% |
| Q4 2022 | $6,765 | -99.9% | 231,587 | -25.6% | 0.03% | -26.7% |
| Q3 2022 | $8,223,000 | -1.0% | 311,220 | +66.5% | 0.04% | +7.1% |
| Q2 2022 | $8,303,000 | +20.2% | 186,873 | +33.8% | 0.04% | +50.0% |
| Q1 2022 | $6,908,000 | +28.2% | 139,695 | +31.9% | 0.03% | +40.0% |
| Q4 2021 | $5,388,000 | -25.3% | 105,879 | -18.2% | 0.02% | -28.6% |
| Q3 2021 | $7,213,000 | -35.6% | 129,430 | -50.5% | 0.03% | -33.3% |
| Q2 2021 | $11,200,000 | +26.0% | 261,703 | +22.9% | 0.04% | +20.0% |
| Q1 2021 | $8,890,000 | +11.3% | 213,009 | +24.2% | 0.04% | +12.9% |
| Q4 2020 | $7,988,000 | +11.5% | 171,484 | +1.7% | 0.03% | +3.3% |
| Q3 2020 | $7,167,000 | +26.5% | 168,699 | +42.9% | 0.03% | +25.0% |
| Q2 2020 | $5,664,000 | +39.9% | 118,056 | +34.1% | 0.02% | +4.3% |
| Q1 2020 | $4,049,000 | +185.5% | 88,013 | +272.9% | 0.02% | +283.3% |
| Q4 2019 | $1,418,000 | -17.8% | 23,600 | -22.6% | 0.01% | -14.3% |
| Q3 2019 | $1,725,000 | -11.1% | 30,493 | -12.6% | 0.01% | -22.2% |
| Q2 2019 | $1,941,000 | +824.3% | 34,873 | +740.7% | 0.01% | +800.0% |
| Q1 2019 | $210,000 | +73.6% | 4,148 | +37.9% | 0.00% | 0.0% |
| Q4 2018 | $121,000 | +5.2% | 3,008 | +82.1% | 0.00% | – |
| Q3 2018 | $115,000 | -42.8% | 1,652 | -56.1% | 0.00% | -100.0% |
| Q4 2017 | $201,000 | -55.9% | 3,761 | -50.8% | 0.00% | -50.0% |
| Q3 2017 | $456,000 | – | 7,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |